ATF5 and prostate carcinoma: To identify cellular targets of DN-ATF5, PC3 prostate cancer cells were transfected with GFP-FLAG-DN-ATF5, and extracts were subjected to pull-down with anti-FLAG beads followed by SDS-PAGE and then LC-MS/MS.